Bryn Pharma: Funding, Investors & Team (Oct 2026)
Bryn Pharma is a pharmaceutical company that offers nasal-based epinephrine for anaphylaxis. Its bi-dose intranasal device is an alternative to epinephrine auto-injectors and is needle-free. It is easy to use and portable enabling patients to treat allergic reactions or anaphylactic reactions.
Bryn Pharma has raised $15.0M across 1 funding round on record, the most recent an undisclosed round of $15.0M announced in May 2023.
That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.
Bryn Pharma Company Profile and Key Stats
Latest funding round on record: May 2023.
Bryn Pharma Funding Rounds
Bryn Pharma Founders and Leadership Team
Contact details for the Bryn Pharma team: 1 of 1 has an email address on file.
Start 14-day free trial →Bryn Pharma Funding Compared to Other Health Care Startups
Bryn Pharma's latest round of $15.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Bryn Pharma in Health Care and Beverly Hills
Companies Similar to Bryn Pharma
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Aptatek is developing cutting edge technologies for portable disease management devices that will improve…
Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…
Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…
For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…
Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…
Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…
People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…
Bryn Pharma Funding FAQs
What does Bryn Pharma do?
Bryn Pharma is a pharmaceutical company that offers nasal-based epinephrine for anaphylaxis. Its bi-dose intranasal device is an alternative to epinephrine auto-injectors and is needle-free. It is easy to use and portable enabling patients to treat allergic reactions or anaphylactic reactions.
How much funding has Bryn Pharma raised?
Bryn Pharma has raised $15.0M across 1 round on record. The most recent is an undisclosed round of $15.0M announced in May 2023.
When did Bryn Pharma last raise funding?
Bryn Pharma's most recent funding round on record is an undisclosed round of $15.0M, announced in May 2023.
Who founded Bryn Pharma?
FundedIQ lists Michelle Lobel (Founder) at Bryn Pharma.
Where is Bryn Pharma headquartered?
Bryn Pharma is based in Beverly Hills, California, United States.
How many employees does Bryn Pharma have?
Bryn Pharma is in the 11-50 employee band.
How does Bryn Pharma's funding compare to other Health Care startups?
Bryn Pharma's latest round of $15.0M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.
About FundedIQ's Bryn Pharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Bryn Pharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.